Olgu Sunumu
BibTex RIS Kaynak Göster

“Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?

Yıl 2015, Cilt: 2 Sayı: 5, 316 - 17, 06.07.2015
https://doi.org/10.17546/msd.09431

Öz

We hereby describe a 46-year woman with nephrotic syndrome and new-onset breast cancer. This patient admitted to our hospital with peripheral edema and a mass in her right breast. Membranous glomerulonephritis (MGN) was the etiology of nephrotic syndrome. MGN has been reported in association with a wide variety of solid neoplastic diseases, although rarely occurs as a complication of breast carcinoma. We report a rare and a resistant case of MGN, who was concomitant diagnosed with breast cancer and there was no improvement in proteinuria although breast cancer was under-controlled with cheomotheraphy and surgery. 

Kaynakça

  • Valcamonico F, Ferrari V, Simoncini E, Gregorini G, Vassalli L, Amoroso V., et al. Paraneoplastic Nephrotic Syndrome in Advanced Breast Cancer Patient. A Case Report. Tumori 2004; 90 (1): 154-156.
  • Eagen JW, Lewis EJ. Glomerulopathies of neoplasia. Kidney Int 1977; 11:297-306.
  • Pai P, Bone JM, McDicken I, Bell GM. Solid tumour and glomerulopathy. Q J Med 1996; 89:361-367.
  • Ozawa T, Pluss R, Lacher J, Boadecker E, Guggenheim S, Hammond W., et al. Endogenous immune complex nephropathy associated with malignancy: studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterisation of tumour specific antigen and antibody and circulating immune complexes. Q J Med 1975; 44:523-541.
  • Gagliano RG, Costanzi JJ, Beathard GA, Sarles HE, Bell JD. The Nephrotic Syndrome Associated with Neoplasia: An Unusual Paraneoplastic Syndrome Report of a Case and Review of the Literature. Am J Med 1976; 60:1026-1031.
Yıl 2015, Cilt: 2 Sayı: 5, 316 - 17, 06.07.2015
https://doi.org/10.17546/msd.09431

Öz

Kaynakça

  • Valcamonico F, Ferrari V, Simoncini E, Gregorini G, Vassalli L, Amoroso V., et al. Paraneoplastic Nephrotic Syndrome in Advanced Breast Cancer Patient. A Case Report. Tumori 2004; 90 (1): 154-156.
  • Eagen JW, Lewis EJ. Glomerulopathies of neoplasia. Kidney Int 1977; 11:297-306.
  • Pai P, Bone JM, McDicken I, Bell GM. Solid tumour and glomerulopathy. Q J Med 1996; 89:361-367.
  • Ozawa T, Pluss R, Lacher J, Boadecker E, Guggenheim S, Hammond W., et al. Endogenous immune complex nephropathy associated with malignancy: studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterisation of tumour specific antigen and antibody and circulating immune complexes. Q J Med 1975; 44:523-541.
  • Gagliano RG, Costanzi JJ, Beathard GA, Sarles HE, Bell JD. The Nephrotic Syndrome Associated with Neoplasia: An Unusual Paraneoplastic Syndrome Report of a Case and Review of the Literature. Am J Med 1976; 60:1026-1031.
Toplam 5 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Vaka Sunumu
Yazarlar

Ezgi Yenigun

Didem Turgut

Erdem Alaguney

Ramazan Ozturk

Serhan Piskinpasa

Fatih Dede Bu kişi benim

Yayımlanma Tarihi 6 Temmuz 2015
Yayımlandığı Sayı Yıl 2015 Cilt: 2 Sayı: 5

Kaynak Göster

APA Yenigun, E., Turgut, D., Alaguney, E., Ozturk, R., vd. (2015). “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Medical Science and Discovery, 2(5), 316-17. https://doi.org/10.17546/msd.09431
AMA Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Med Sci Discov. Temmuz 2015;2(5):316-17. doi:10.17546/msd.09431
Chicago Yenigun, Ezgi, Didem Turgut, Erdem Alaguney, Ramazan Ozturk, Serhan Piskinpasa, ve Fatih Dede. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery 2, sy. 5 (Temmuz 2015): 316-17. https://doi.org/10.17546/msd.09431.
EndNote Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F (01 Temmuz 2015) “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Medical Science and Discovery 2 5 316–17.
IEEE E. Yenigun, D. Turgut, E. Alaguney, R. Ozturk, S. Piskinpasa, ve F. Dede, ““Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?”, Med Sci Discov, c. 2, sy. 5, ss. 316–17, 2015, doi: 10.17546/msd.09431.
ISNAD Yenigun, Ezgi vd. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery 2/5 (Temmuz 2015), 316-17. https://doi.org/10.17546/msd.09431.
JAMA Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Med Sci Discov. 2015;2:316–17.
MLA Yenigun, Ezgi vd. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery, c. 2, sy. 5, 2015, ss. 316-17, doi:10.17546/msd.09431.
Vancouver Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Med Sci Discov. 2015;2(5):316-17.